DocDollars

Mirati Therapeutics, Inc.

NJ · United States · Reporting entity ID 100001376985

Total reported 2019–2025
$100.6M
#97 of 2,960 reporting companies — 0.1% of all reported industry payments
$2.03M in general payments across 15,648 records, plus $98.6M in research funding across 11,952 records.

How it breaks down

General payments $2,031,675
Research funding $98,595,864

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Mirati Therapeutics, Inc. reported $100.6M to US doctors and teaching hospitals from 2019 to 2025, ranking #97 of 2,960 reporting companies. 98% of that was research funding and 2% general payments such as consulting, speaking, food and travel. 15,648 general payment records and 11,952 research records were filed.

Common questions about Mirati Therapeutics, Inc.

How much has Mirati Therapeutics, Inc. paid US doctors?

Mirati Therapeutics, Inc. reported $100,627,539 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,031,675 in general payments, $98,595,864 in research funding.

How does Mirati Therapeutics, Inc. rank among drug and device companies?

It ranks #97 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Mirati Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.